Stephen Broderick - Concepedia

Author

Stephen Broderick

Also Known As

Graham Colditz, J Bell, Page Bouchard, S Broderick, S. Broderick, S. R. Broderick, S.R. Broderick, Stacy Broderick, Stephen Broderick, Stephen R Broderick

183

Publications

12.5K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Washington University in St. Louis Johns Hopkins Medicine Memorial Sloan Kettering Cancer Center Sidney Kimmel Comprehensive Cancer Center

About

Stephen Broderick is an author at Johns Hopkins University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	54	8K
2	Health Sciences	13	14	1.3K
3	Public Health	3	3	65
4	Engineering	1	1	1.6K
5	Cardiothoracic Surgery	1	1	129

Stephen Broderick

Publications

11.9K

Citations

H-Index

Page 1

	Year	Citations
Somatic mutations affect key pathways in lung adenocarcinoma Li Ding, Gad Getz, David A. Wheeler, Nature Somatic VariantSomatic MutationsBronchial NeoplasmCancer GeneticsSystems Biology	2008	2.7K
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer Patrick M. Forde, Jamie E. Chaft, Kellie N. Smith, New England Journal of Medicine	2018	2.1K
<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib James Bean, Cameron Brennan, Jin‐Yuan Shih, Proceedings of the National Academy of Sciences Harbors Met AmplificationEngineeringPathologyTumor BiologyOncology	2007	1.6K
Characterizing the cancer genome in lung adenocarcinoma Barbara A. Weir, Michele Sue‐Ann Woo, Gad Getz, Nature	2007	1.1K
Epigenetic therapy inhibits metastases by disrupting premetastatic niches Zhihao Lü, Jianling Zou, Shuang Li, Nature Epigenetic ChangeEpigenomicsPremetastatic NichesMedicineCell Biology	2020	330
Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer Matthew J. Bott, Stephen C. Yang, Bernard J. Park, Journal of Thoracic and Cardiovascular Surgery Surgical OncologyInitial ResultsMedicineMultiple Pulmonary NoduleBronchial Neoplasm	2018	284
Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma Jenifer L. Marks, Stephen Broderick, Qin Zhou, Journal of Thoracic Oncology Kras MutationsSurgical OncologyMedicinePathologyCancer Genomics	2008	272
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors Dhananjay Chitale, Yongxing Gong, Barry S. Taylor, Oncogene Integrated Genomic AnalysisOncologyTumor HeterogeneityMedicineCancer Genomics	2009	230
Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer Pamela Samson, Aalok Patel, Tasha Garrett, The Annals of Thoracic Surgery Clinical StageSurgical OncologyMedicineCancer ManagementBronchial Neoplasm	2015	207
Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline Bryan J. Schneider, Megan E. Daly, Erin B. Kennedy, Journal of Clinical Oncology Adaptive RadiotherapyRadiation MedicineSurgical OncologyRadiation TherapyMedicine	2017	182

Page 1